Please note, this article contains references to Ashfield Engage which has now become Inizio Engage

Ashfield Engage acquires Nuvera to enhance Patient Solutions offering

Ashfield Engage, part of UDG Healthcare plc., announces the completion of the acquisition of Nuvera LLC, a US-based healthcare consulting firm specializing in patient support programs.

An end-to-end strategic offering

Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment experiences. This expertise will enhance Ashfield Engage’s Patient Solutions capabilities and create an end-to-end strategic offering across their client’s product lifecycles.

Following the acquisition, Ashfield Engage and Nuvera will offer integrated specialist support and services including late-phase clinical trial experience, implementation and post-commercialization satisfaction benchmarking and service optimization.

„Combining the expertise of Ashfield Engage and Nuvera creates a wealth of opportunities for our clients and patients“.

Strategic and operational insight

Nareda Mills, Global President, Patient Solutions, Ashfield Engage said: “Combining the expertise of Ashfield Engage and Nuvera creates a wealth of opportunities for our clients and patients. By leveraging the strategic and operational insight of both organizations we will be able to bring our program implementation experience to the table earlier and influence the overall strategic direction of patient support, leading to better programs and results.

“Our combined expertise and capabilities will also allow greater visibility across the market landscape to better refine and refresh programs as new market challenges arise. This end-to-end understanding of the treatment experience will advance our patient programs, building best in class services that are meaningful for patients.

“The Nuvera team is an exceptional asset to add to Ashfield Engage, they are pioneers in redefining the treatment experience and I am truly excited for what lies ahead.”

Industry leading patient support strategies

Founded in 2010, Nuvera has partnered with a multitude of larger pharmaceutical and emerging biotech commercial teams for over a decade, helping to develop industry leading patient support strategies and capabilities.

Greg Klein, Founder and Managing Partner, Nuvera added: “We are thrilled to become part of Ashfield Engage which will lead to the whole being greater than the sum of our parts. Ashfield’s breadth of engagements combined with Nuvera’s strategic design capabilities will lead to an overall greater impact for our clients and their patients. From complementary cultures to global exposure, we are excited by our new potential.

“We are passionate and value the role we play creating solutions that positively impact patients, and we will continue to provide the same experience for clients, now with the added benefit of the Ashfield Engage team’s expertise and capabilities.”

Bourne Partners served as exclusive financial advisor to Nuvera in the structuring and negotiation of this transaction.

Strategic and operational insight

Nareda Mills, Global President, Patient Solutions, Ashfield Engage said: “Combining the expertise of Ashfield Engage and Nuvera creates a wealth of opportunities for our clients and patients. By leveraging the strategic and operational insight of both organizations we will be able to bring our program implementation experience to the table earlier and influence the overall strategic direction of patient support, leading to better programs and results.

“Our combined expertise and capabilities will also allow greater visibility across the market landscape to better refine and refresh programs as new market challenges arise. This end-to-end understanding of the treatment experience will advance our patient programs, building best in class services that are meaningful for patients.

“The Nuvera team is an exceptional asset to add to Ashfield Engage, they are pioneers in redefining the treatment experience and I am truly excited for what lies ahead.”

Industry leading patient support strategies

Founded in 2010, Nuvera has partnered with a multitude of larger pharmaceutical and emerging biotech commercial teams for over a decade, helping to develop industry leading patient support strategies and capabilities.

Greg Klein, Founder and Managing Partner, Nuvera added: “We are thrilled to become part of Ashfield Engage which will lead to the whole being greater than the sum of our parts. Ashfield’s breadth of engagements combined with Nuvera’s strategic design capabilities will lead to an overall greater impact for our clients and their patients. From complementary cultures to global exposure, we are excited by our new potential.

“We are passionate and value the role we play creating solutions that positively impact patients, and we will continue to provide the same experience for clients, now with the added benefit of the Ashfield Engage team’s expertise and capabilities.”

Bourne Partners served as exclusive financial advisor to Nuvera in the structuring and negotiation of this transaction.